Cartilage repair is a process that covers the treatment of damaged cartilage through different modalities, such as chondroplasty, implantation of autologous chondrocytes, osteochondral allograft and juvenile allograft fragments to restore normal connective tissue functions.

It is anticipated that the cartilage repair market will grow considerably in the near future, due to different factors such as the increase in obesity and the sedentary lifestyle among the population, the increase in the elderly population and the increase in the prevalence of arthritis. Around the world.
However, the high costs associated with cartilage repair procedures and the unclear regulatory scenario are the key factors that are expected to impede market growth. On the contrary, it is anticipated that emerging markets such as India and China will provide lucrative growth opportunities to market participants during the forecast period.

Get Sample Report @ https://www.alliedmarketresearch.com/request-sample/4644

According to Allied Market Research the global market was valued at $713 million in 2017, and is projected to reach $2,195 million by 2025, growing at a CAGR of 15.0% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.

By modality, chondroplasty and micro fracture accounted for more than a quarter of the global market for cartilage repair in 2017. In terms of application, the knee segment obtained almost half of the market share in 2017, and is projected to exhibit a prominent growth rate, due to the increase in the prevalence of knee osteoarthritis worldwide.

Key Findings of the Cartilage Repair Market:
• Hyaline cartilage accounted for almost two thirds of the market share of cartilage repair in 2017.
• It is anticipated that the application of the knee will grow with the highest CAGR throughout the prognosis period.
• North America accounted for more than a third of the global cartilage repair market in 2017.
• It is anticipated that Asia-Pacific will grow at the highest rate during the analysis period, followed by LAMEA.

Among end users, hospitals and clinics generated the highest income in 2017, due to different factors such as the availability of different treatment options (chondroplasty, osteochondral autograft transplantation and others) under one roof, palliative care and diagnosis. By region, North America was the highest income contributor in the global market in 2017.

North America was the main contributor of revenue to the global market in 2017, due to the high rate of adoption of cartilage repair products. However, Asia Pacific is expected to grow to the highest CAGR of 16.5% from 2018 to 2025, due to the increase in disposable income; increase in research, development and innovation activities; and increase awareness towards cartilage repair products.

Send Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/4644